Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Im

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
American Journal of Hematology|February 12, 2024
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centersYasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, et al.
Blood Advances|May 27, 2026
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 studyNoa G Holtzman, Annie Im, Lauren M Curtis, et al.
Transplantation and Cellular Therapy|April 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group ReportKirsten M Williams, Yoshihiro Inamoto, Annie Im, et al.
British Journal of Haematology|September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantationPeter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
Blood|July 15, 2021
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar StudyCorey Cutler, Stephanie J Lee, Sally Arai, et al.
Bone Marrow Transplantation|May 6, 2022
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationRachel Phelan, Annie Im, Rebecca L Hunter, et al.
Transplantation and Cellular Therapy|November 10, 2021
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationRachel Phelan, Annie Im, Rebecca L Hunter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant CyclophosphamideAnnie Im, Armin Rashidi, Tao Wang, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
American Journal of Hematology|February 12, 2024
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centersYasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, et al.
Blood Advances|May 27, 2026
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 studyNoa G Holtzman, Annie Im, Lauren M Curtis, et al.
Transplantation and Cellular Therapy|April 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group ReportKirsten M Williams, Yoshihiro Inamoto, Annie Im, et al.
British Journal of Haematology|September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantationPeter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
Blood|July 15, 2021
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar StudyCorey Cutler, Stephanie J Lee, Sally Arai, et al.
Bone Marrow Transplantation|May 6, 2022
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationRachel Phelan, Annie Im, Rebecca L Hunter, et al.
Transplantation and Cellular Therapy|November 10, 2021
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationRachel Phelan, Annie Im, Rebecca L Hunter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant CyclophosphamideAnnie Im, Armin Rashidi, Tao Wang, et al.
Pageof 5